BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
19.60
+1.33 (7.28%)
At close: Jan 27, 2026, 4:00 PM EST
20.09
+0.49 (2.50%)
After-hours: Jan 27, 2026, 6:51 PM EST
BioAge Labs Market Cap
BioAge Labs has a market cap or net worth of $818.35 million as of January 27, 2026. Its market cap has increased by 348.48% in one year.
Market Cap
818.35M
Enterprise Value
529.63M
1-Year Change
348.48%
Ranking
Category
Stock Price
$19.60
Market Cap Chart
Since the IPO on September 26, 2024, BioAge Labs's market cap has increased from $615.01M to $818.35M, an increase of 33.06%. That is a compound annual growth rate of 23.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 26, 2026 | 762.82M | 60.81% |
| Dec 31, 2025 | 474.36M | 128.54% |
| Dec 31, 2024 | 207.56M | -66.25% |
| Sep 26, 2024 | 615.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amphastar Pharmaceuticals | 1.22B |
| Cronos Group | 1.03B |
| Tilray Brands | 1.02B |
| Pacira BioSciences | 881.94M |
| Ironwood Pharmaceuticals | 842.68M |
| Esperion Therapeutics | 786.34M |
| BGM Group | 665.93M |
| Emergent BioSolutions | 625.51M |